GLP1R and Insulin resistance: Suppress acylation of DAGs into triglycerides; primarily reduce intestinal lipid absorption by increasing intestinal fatty acid oxidation and GLP-1 secretion; prevent weight gain, hepatic steatosis, and insulin resistance